You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Donor-specific antibodies (DSA)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nanoparticle for DSA Removal

Recruiting
  • Kidney Failure
  • Presence of Donor Specific Antibodies
    • Zurich, ZH, Switzerland
      University Hospital Zurich, Division of Anaesthesiology
    Mar 11, 2022

    Immunoglobulins, Plasmapheresis and Rituximab in Lung

    Recruiting
    • Lung Transplantation
    • Donor-specific Anti-human Leukocyte Antigen(HLA) Antibodies
    • blood samples
    • Hannover, Germany
      Hannover Medical School, Department of Cardiothoracic, Transplan
    Aug 30, 2021

    Lung Transplant Recipient, Donor Specific Antibodies, Antibody Mediated Rejection Trial in France (bronchoscopy.)

    Recruiting
    • Lung Transplant Recipient
    • +2 more
    • bronchoscopy.
    • Le Plessis Robinson, France
    • +4 more
    Feb 11, 2022

    Donor-Specific Antibodies in Immunized Living Donor Kidney

    Completed
    • Renal Failure
      • (no location specified)
      Jun 28, 2022

      Renal Transplant Trial in Seoul (Rituximab, intravenous immune globulin)

      Completed
      • Renal Transplant
      • Seoul, Korea, Republic of
      • +1 more
      Oct 25, 2022

      Expanding Scope of Post-transplant HLA-specific Antibody

      Not yet recruiting
      • Kidney Transplant
      • +7 more
      • cf-DNA
      • +2 more
      • Liverpool, Merseyside, United Kingdom
        Liverpool University Hospitals NHS Foundation Trust
      Aug 29, 2023

      Kidney Transplant Rejection, Antibody-mediated Rejection, Kidney Transplant Failure Trial in Berlin (Kidney allograft biopsy

      Active, not recruiting
      • Kidney Transplant Rejection
      • +2 more
      • Kidney allograft biopsy depending on donor-derived cell-free DNA levels
      • Berlin, Germany
        Charité-Universitätsmedizin
      Jul 22, 2022

      Donor Specific B Cells and Antibody Mediated Rejection

      Terminated
      • Sensitized Kidney Transplant Recipients
        • Madison, Wisconsin
          University of Wisconsin Hospital and Clinics
        Dec 13, 2021

        Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)

        Not yet recruiting
        • Renal Transplant Rejection
        • Induction Therapy
        • (no location specified)
        Sep 22, 2022

        Kidney Transplant Rejection Trial in Los Angeles (Extended-release tacrolimus, Immediate-release tacrolimus)

        Recruiting
        • Kidney Transplant Rejection
        • Extended-release tacrolimus
        • Immediate-release tacrolimus
        • Los Angeles, California
          Cedars-Sinai Medical Center
        Jan 18, 2022

        Kidney Transplant Rejection Trial in Warsaw (Anti-HLA donor-specific antibodies monitoring)

        Active, not recruiting
        • Kidney Transplant Rejection
        • Anti-HLA donor-specific antibodies monitoring
        • Warsaw, Poland
          Department of Transplantation Medicine, Nephrology and Internal
        Mar 8, 2021

        Donor-specific Antibodies After Liver Transplantation

        Completed
        • Liver Transplant
          • Lille, France
            CHRU, Hôpital Claude Huriez
          Mar 24, 2021

          Subclass of Donor-specific Antibody asRisk Factor of Antibody

          Active, not recruiting
          • Antibody-mediated Rejection
            • Montpellier, Hérault, France
              CHU Lapeyronie
            Jan 18, 2023

            Antibody-mediated Rejection, Kidney Transplant; Complications, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

            Active, not recruiting
            • Antibody-mediated Rejection
            • +5 more
            • Los Angeles, California
              Norko Ammerman
            Mar 25, 2022

            Trial of Kidney Tx Patients Treated With Imlifidase or PE

            Recruiting
            • Kidney Transplant Rejection
            • Vienna, Austria
            • +4 more
            Apr 7, 2022

            Antibody-mediated Rejection, Allosensitization Trial in New York (Isatuximab, bone marrow biopsy)

            Not yet recruiting
            • Antibody-mediated Rejection
            • Allosensitization
            • New York, New York
              NYU Langone Health
            May 16, 2023

            Kidney Disease, End-Stage, Donor Specific Antibodies, Acute Rejection of Renal Transplant Trial (Envarsus XR)

            Withdrawn
            • Kidney Disease, End-Stage
            • +2 more
            • Envarsus XR
            • (no location specified)
            Dec 10, 2020

            Donor-Derived Cell-Free DNA With Tocilizumab Treatment for

            Active, not recruiting
            • Rejection Chronic Renal
            • Kidney Transplant Rejection
              • Los Angeles, California
                Cedars-Sinai Medical Center
              Jul 18, 2022

              Lung Graft Dysfunction Trial (Blood collection T0, Blood collection 6 months)

              Not yet recruiting
              • Lung Graft Dysfunction
              • Blood collection T0
              • Blood collection 6 months
              • (no location specified)
              Oct 27, 2023

              Heart Transplant, Immunosuppression, Allograft Trial (HeartCare)

              Not yet recruiting
              • Heart Transplant
              • +2 more
              • HeartCare
              • (no location specified)
              Jul 12, 2022

              Kidney Transplantation in Highly Sensitized Patients Trial in United States (drug, procedure, other)

              Recruiting
              • Kidney Transplantation in Highly Sensitized Patients
              • Birmingham, Alabama
              • +12 more
              Jan 12, 2023

              Kidney Failure, Chronic, End-Stage Renal Disease, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

              Active, not recruiting
              • Kidney Failure, Chronic
              • +6 more
              • Los Angeles, California
                Norko Ammerman
              Mar 25, 2022

              Highly Sensitized Prospective Kidney Transplant Recipients Trial in Durham (carfilzomib, belatacept, Bone marrow aspiration)

              Recruiting
              • Highly Sensitized Prospective Kidney Transplant Recipients
              • carfilzomib
              • +2 more
              • Durham, North Carolina
                Duke Transplant Center, Duke University Medical Center
              Jan 11, 2022

              Torquetenovirus Load in Chinese Renal Transplant Recipients

              Not yet recruiting
              • Kidney Transplant Rejection
              • +3 more
                • Hangzhou, China
                • +3 more
                Feb 5, 2023

                Kidney Transplant Recipients Trial in Xi'an (Mycophenolate Mofetil Capsules)

                Recruiting
                • Kidney Transplant Recipients
                • Mycophenolate Mofetil Capsules
                • Xi'an, Shaanxi, China
                  First Affiliated Hospital Xi'an Jiaotong University
                May 25, 2022